X

Procter & Gamble Health Ltd Stock Analysis

Mid Cap
Evaluated by 1340 users | BSE: 500126 | NSE: PGHL |
Pharmaceuticals & Drugs

Procter & Gamble Health Limited (formerly Merck Limited) was set up in India as one of Merck’s Asian subsidiaries in 1967.  It was also the first Merck Group Company to go public in the year 1981.  Till 2018, the Company was...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Procter & Gamble Health Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good
Value Creation
 Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Jun'20
Return on Capital Employed 17.83%16.88%17.48%11%7.87%9.19%12.33%11.54%73.32%20.8%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 5095906877988679409936981,288904
Y-o-Y Gr. Rt.-15.8%16.6%16.1%8.7%8.3%5.7%-29.7%84.5%-29.8%
Adjusted EPS (Rs.) 43.6838.4147.0733.3625.5431.7146.6348.57502.09102.21
Y-o-Y Gr. Rt.--12.1%22.6%-29.1%-23.4%24.2%47.1%4.2%933.8%-79.6%
Book Value per Share (Rs.) 208.69247.04291.36315.08333.92356.36399.89441.72927.78363.21
Adjusted Net Profit 72.563.878.155.442.452.677.480.6833170
Net Op. Cash Flow (Rs. Cr.) 6618.854.30.5583.510753.7-130157
Debt to Cash Flow from Ops 0000000000
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Procter & Gamble Health Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 6.6%0.8%-3.1%-29.8%
Adjusted EPS 9.9%32%29.9%-79.6%
Book Value per Share 6.41.7-3.2-60.9
Share Price 29.8% 56.5% 41.7% 50.1%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Jun'20
Return on Equity (%) 17.8216.8617.48117.879.1912.3311.5473.3220.8
Operating Profit Margin (%) 14.4912.3415.369.656.89.0211.6610.1316.3223.42
Net Profit Margin (%) 14.2410.8211.376.944.895.67.811.5564.718.77
Debt to Equity 0000000000
Working Capital Days 128273365235248381367503321346
Cash Conversion Cycle 32577174858266881512
Entity Percentage Holding
Promoters 51.82%
Institutions 18.19%
Non-Institutions 30.00%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

MoneyWorks4Me analysed the past 10-year performance of Procter & Gamble Health Ltd and arrived at the following conclusion:

Past 10 year's financial track record indicates that Procter & Gamble Health Ltd is a good quality company. However, for specific investment actions please connect with your investment advisor.

The 5-year analysis of Procter & Gamble Health Ltd's performance infers:

Procter & Gamble Health Ltd earnings have grown by 32%, whereas share price has appreciated 56.5% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Procter & Gamble Health Ltd share prices over the last 10 years. Here is what we found out:

Procter & Gamble Health Ltd share price has appreciated 26.3% annually over the past ten years.

Procter & Gamble Health Limited (formerly Merck Limited) was set up in India as one of Merck’s Asian subsidiaries in 1967.  It was also the first Merck Group Company to go public in the year 1981.  Till 2018, the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country.

On December 1st, 2018, P&G successfully completed the

Procter & Gamble Health Limited (formerly Merck Limited) was set up in India as one of Merck’s Asian subsidiaries in 1967.  It was also the first Merck Group Company to go public in the year 1981.  Till 2018, the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country.

On December 1st, 2018, P&G successfully completed the acquisition of Merck’s Consumer Health business further to approval of all relevant regulatory authorities and the fulfilment of other customary closing conditions. Procter & Gamble Overseas India B.V. now holds 51.81% of the share capital in Merck Limited, while the remaining 48.19% is traded on the Bombay Stock Exchange Ltd. and National Stock Exchange of India Ltd.

Currently, Procter & Gamble Health Limited (formerly Merck Limited) is one of India’s largest VMS Companies manufacturing and marketing over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle and improved quality of life. Its trusted products are household names in India protecting and supporting millions of people at every stage of life. With a strong portfolio of brands backed by science and trusted by doctors, pharmacists and consumers, Procter & Gamble Health Limited combines the best of P&G and Legacy Merck’s Consumer Health capabilities and cultures. Together we are working towards leveraging our combined expertise to develop categories and brands that meet today’s needs and tomorrow’s opportunities.

Situated at Usgaon, Goa, the company’s Manufacturing Site has grown from a small Vitamin E producing unit to a big composite plant manufacturing pharma and chemical products.

Business area of the company

Till 2018, the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country. The company is one of India’s largest VMS Companies manufacturing and marketing over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle and improved quality of life. Its trusted products are household names in India protecting and supporting millions of people at every stage of life.

Brands of the company

  • Neurobion
  • Evion
  • Seven Seas
  • Nasivion
  • Polybion
  • Livogen

Awards and achievements

  • 2015-16: Merck Goa plant was awarded 1st prize in safety called “Gomant Sarvochcha Suraksha Puraskar”. This is consecutive 2nd time Merck Goa plant bagged 1st prize in safety. Prior to that Merck Goa plant bagged 2nd prize in safety “Gomant Uchcha Suraksha Puraskar” for two consecutive years.
  • 2016-17: Consumer activation done for Neurobion under ‘True Heroes’ campaign won laurels at the Global level to receive President’s Award in 2017.
  • 2017-18: Nasivion continued to be the Doctors’ trusted No. 1 Nasal Decongestant.
  • 2019-20: Neurobion bagged three awards viz. Nicholas Hall Marketing Excellence Award; CIMS Trusted Brand of the Year; and ABP News Brand Excellence Award.
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback